These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26535595)

  • 1. Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.
    Buttgereit F; Kent JD; Holt RJ; Grahn AY; Rice P; Alten R; Yazici Y
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):168-77. PubMed ID: 26535595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.
    Alten R; Holt R; Grahn A; Rice P; Kent J; Buttgereit F; Gibofsky A
    Scand J Rheumatol; 2015; 44(5):354-8. PubMed ID: 26114379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Lancet; 2008 Jan; 371(9608):205-14. PubMed ID: 18207016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Ann Rheum Dis; 2010 Jul; 69(7):1275-80. PubMed ID: 20542963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids.
    Cutolo M; Iaccarino L; Doria A; Govoni M; Sulli A; Marcassa C
    Clin Exp Rheumatol; 2013; 31(4):498-505. PubMed ID: 23415134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.
    Dikranian AH; Mallay R; Marshall M; Francis-Sedlak M; Holt RJ
    Rheumatol Ther; 2017 Dec; 4(2):363-374. PubMed ID: 28819927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F; Naty S; Bruno C; Grembiale RD
    Rev Recent Clin Trials; 2017; 12(2):124-128. PubMed ID: 28356031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone.
    Alten R; Döring G; Cutolo M; Gromnica-Ihle E; Witte S; Straub R; Buttgereit F
    J Rheumatol; 2010 Oct; 37(10):2025-31. PubMed ID: 20682671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Is the Relationship Between Morning Symptoms and Measures of Disease Activity in Patients With Rheumatoid Arthritis?
    Boers M; Buttgereit F; Saag K; Alten R; Grahn A; Storey D; Rice P; Kirwan J
    Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1202-1209. PubMed ID: 25807939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2).
    Buttgereit F; Mehta D; Kirwan J; Szechinski J; Boers M; Alten RE; Supronik J; Szombati I; Romer U; Witte S; Saag KG
    Ann Rheum Dis; 2013 Feb; 72(2):204-10. PubMed ID: 22562974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
    Kirwan JR; Buttgereit F
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
    Lee EY; Lee EB; Park BJ; Lee CK; Yoo B; Lim MK; Shim SC; Sheen DH; Seo YI; Kim HA; Baek HJ; Song YW
    Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F; Gibofsky A
    Expert Opin Pharmacother; 2013 Jun; 14(8):1097-106. PubMed ID: 23594208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
    Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
    Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis.
    Pincus T; Cutolo M
    Neuroimmunomodulation; 2015; 22(1-2):46-50. PubMed ID: 25227901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():26-9. PubMed ID: 23259655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of body mass index in a tight controlled methotrexate-based strategy with prednisone in early rheumatoid arthritis: side effect of the prednisone or better control of disease activity?
    Jurgens MS; Jacobs JW; Geenen R; Bossema ER; Bakker MF; Bijlsma JW; van Albada-Kuipers IA; Ehrlich JC; Lafeber FP; Welsing PM;
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):88-93. PubMed ID: 22807253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified-release prednisone: in patients with rheumatoid arthritis.
    Henness S; Yang LP
    Drugs; 2013 Dec; 73(18):2067-76. PubMed ID: 24249648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.